Sarah J. Hill, MD, PhD

Dana-Farber Cancer Institute

Academic Titles

Assistant Professor, Medicine, Harvard Medical School

Research Program Affiliation

Member, Gynecologic Cancers

Research Abstract

Dr. Sarah Hill, M.D./Ph.D., is a physician scientist in the Department of Medical Oncology at Dana-Farber Cancer Institute. She completed her A.B. at Harvard College, her Ph.D. at Harvard University in the laboratory of Dr. David Livingston at Dana-Farber Cancer Institute, and her M.D. at Harvard Medical School in the Harvard-MIT HST program. Upon graduation from the Harvard M.D./Ph.D. program, she completed a brief clinical residency. She joined the faculty at Dana-Farber as an independent investigator immediately upon completion of her residency without any post-doctoral training and won an NIH Early Independence Award with the support of her Ph.D. mentor Dr. Livingston.

The Hill lab is part of the Department of Medical Oncology and Division of Molecular and Cellular Oncology at Dana-Farber Cancer Institute. The mission of the Hill Lab is to develop a deep mechanistic understanding of breast, ovarian, and endometrial cancer development and tumor biology which we will harness to make these cancers more manageable diseases for all patients through the development of effective methods of detection, prevention, and treatment. In pursuit of this mission, the Hill lab focuses on understanding the role of the BRCA1 tumor suppressor and cell cycle checkpoints in basic molecular and cellular biology and in breast, ovarian, and endometrial carcinogenesis and tumor biology. We utilize molecular/cellular biology and fluorescence microscopy techniques in ovarian cancer cell lines, and mouse models.